Endothelin receptor expression in the normal and injured spinal cord: Potential involvement in injury-induced ischemia and gliosis

Christopher M. Peters, Scott D. Rogers, James D. Pomonis, Greg F. Egnazyck, Cathy P. Keyser, Julie A. Schmidt, Joseph R. Ghilardi, John E. Maggio, Patrick W Mantyh

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The endothelins (ETs) are a family of peptides that exert their biological effects via two distinct receptors, the endothelin A receptor (ETAR) and the endothelin B receptor (ETBR). To more clearly define the potential actions of ETs following spinal cord injury, we used immunohistochemistry and confocal microscopy to examine the protein expression of ETAR and ETBR in the normal and injured rat spinal cord. In the normal spinal cord, ETAR immunoreactivity (IR) is expressed by vascular smooth muscle cells and a subpopulation of primary afferent nerve fibers. ETBR-IR is expressed primarily by radial glia, a small population of gray and white matter astrocytes, ependymal cells, vascular endothelial cells, and to a lesser extent in smooth muscle cells. Fourteen days following compression injury to the spinal cord, there was a significant upregulation in both the immunoexpression and number of astrocytes expressing the ETBR in both gray and white matter and a near disappearance of ETBR-IR in ependymal cells and ETAR-IR in primary afferent fibers. Conversely, the vascular expression of ETAR and ETBR did not appear to change. As spinal cord injury has been shown to induce an immediate increase in plasma ET levels and a sustained increase in tissue ET levels, ETs would be expected to induce an initial marked vasoconstriction via activation of vascular ETAR/ETBR and then days later a glial hypertrophy via activation of the ETBR expressed by astrocytes. Strategies aimed at blocking vascular ETAR/ETBR and astrocyte ETBRs following spinal cord injury may reduce the resulting ischemia and astrogliosis and in doing so increase neuronal survival, regeneration, and function.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalExperimental Neurology
Volume180
Issue number1
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Endothelin B Receptors
Endothelin Receptors
Gliosis
Endothelin A Receptors
Spinal Cord
Ischemia
Endothelins
Wounds and Injuries
Spinal Cord Injuries
Astrocytes
Blood Vessels
Neuroglia
Smooth Muscle Myocytes
Vasoconstriction
Vascular Smooth Muscle
Nerve Fibers
Confocal Microscopy
Hypertrophy
Action Potentials
Regeneration

Keywords

  • Astrocytes
  • CNS injury
  • Endothelial cells
  • Endothelin
  • Regeneration
  • Secondary injury
  • Smooth muscle cells
  • Vascular

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

Endothelin receptor expression in the normal and injured spinal cord : Potential involvement in injury-induced ischemia and gliosis. / Peters, Christopher M.; Rogers, Scott D.; Pomonis, James D.; Egnazyck, Greg F.; Keyser, Cathy P.; Schmidt, Julie A.; Ghilardi, Joseph R.; Maggio, John E.; Mantyh, Patrick W.

In: Experimental Neurology, Vol. 180, No. 1, 01.03.2003, p. 1-13.

Research output: Contribution to journalArticle

Peters, CM, Rogers, SD, Pomonis, JD, Egnazyck, GF, Keyser, CP, Schmidt, JA, Ghilardi, JR, Maggio, JE & Mantyh, PW 2003, 'Endothelin receptor expression in the normal and injured spinal cord: Potential involvement in injury-induced ischemia and gliosis', Experimental Neurology, vol. 180, no. 1, pp. 1-13. https://doi.org/10.1016/S0014-4886(02)00023-7
Peters, Christopher M. ; Rogers, Scott D. ; Pomonis, James D. ; Egnazyck, Greg F. ; Keyser, Cathy P. ; Schmidt, Julie A. ; Ghilardi, Joseph R. ; Maggio, John E. ; Mantyh, Patrick W. / Endothelin receptor expression in the normal and injured spinal cord : Potential involvement in injury-induced ischemia and gliosis. In: Experimental Neurology. 2003 ; Vol. 180, No. 1. pp. 1-13.
@article{9f6e73821bcb49bfbacdf66a31de1502,
title = "Endothelin receptor expression in the normal and injured spinal cord: Potential involvement in injury-induced ischemia and gliosis",
abstract = "The endothelins (ETs) are a family of peptides that exert their biological effects via two distinct receptors, the endothelin A receptor (ETAR) and the endothelin B receptor (ETBR). To more clearly define the potential actions of ETs following spinal cord injury, we used immunohistochemistry and confocal microscopy to examine the protein expression of ETAR and ETBR in the normal and injured rat spinal cord. In the normal spinal cord, ETAR immunoreactivity (IR) is expressed by vascular smooth muscle cells and a subpopulation of primary afferent nerve fibers. ETBR-IR is expressed primarily by radial glia, a small population of gray and white matter astrocytes, ependymal cells, vascular endothelial cells, and to a lesser extent in smooth muscle cells. Fourteen days following compression injury to the spinal cord, there was a significant upregulation in both the immunoexpression and number of astrocytes expressing the ETBR in both gray and white matter and a near disappearance of ETBR-IR in ependymal cells and ETAR-IR in primary afferent fibers. Conversely, the vascular expression of ETAR and ETBR did not appear to change. As spinal cord injury has been shown to induce an immediate increase in plasma ET levels and a sustained increase in tissue ET levels, ETs would be expected to induce an initial marked vasoconstriction via activation of vascular ETAR/ETBR and then days later a glial hypertrophy via activation of the ETBR expressed by astrocytes. Strategies aimed at blocking vascular ETAR/ETBR and astrocyte ETBRs following spinal cord injury may reduce the resulting ischemia and astrogliosis and in doing so increase neuronal survival, regeneration, and function.",
keywords = "Astrocytes, CNS injury, Endothelial cells, Endothelin, Regeneration, Secondary injury, Smooth muscle cells, Vascular",
author = "Peters, {Christopher M.} and Rogers, {Scott D.} and Pomonis, {James D.} and Egnazyck, {Greg F.} and Keyser, {Cathy P.} and Schmidt, {Julie A.} and Ghilardi, {Joseph R.} and Maggio, {John E.} and Mantyh, {Patrick W}",
year = "2003",
month = "3",
day = "1",
doi = "10.1016/S0014-4886(02)00023-7",
language = "English (US)",
volume = "180",
pages = "1--13",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Endothelin receptor expression in the normal and injured spinal cord

T2 - Potential involvement in injury-induced ischemia and gliosis

AU - Peters, Christopher M.

AU - Rogers, Scott D.

AU - Pomonis, James D.

AU - Egnazyck, Greg F.

AU - Keyser, Cathy P.

AU - Schmidt, Julie A.

AU - Ghilardi, Joseph R.

AU - Maggio, John E.

AU - Mantyh, Patrick W

PY - 2003/3/1

Y1 - 2003/3/1

N2 - The endothelins (ETs) are a family of peptides that exert their biological effects via two distinct receptors, the endothelin A receptor (ETAR) and the endothelin B receptor (ETBR). To more clearly define the potential actions of ETs following spinal cord injury, we used immunohistochemistry and confocal microscopy to examine the protein expression of ETAR and ETBR in the normal and injured rat spinal cord. In the normal spinal cord, ETAR immunoreactivity (IR) is expressed by vascular smooth muscle cells and a subpopulation of primary afferent nerve fibers. ETBR-IR is expressed primarily by radial glia, a small population of gray and white matter astrocytes, ependymal cells, vascular endothelial cells, and to a lesser extent in smooth muscle cells. Fourteen days following compression injury to the spinal cord, there was a significant upregulation in both the immunoexpression and number of astrocytes expressing the ETBR in both gray and white matter and a near disappearance of ETBR-IR in ependymal cells and ETAR-IR in primary afferent fibers. Conversely, the vascular expression of ETAR and ETBR did not appear to change. As spinal cord injury has been shown to induce an immediate increase in plasma ET levels and a sustained increase in tissue ET levels, ETs would be expected to induce an initial marked vasoconstriction via activation of vascular ETAR/ETBR and then days later a glial hypertrophy via activation of the ETBR expressed by astrocytes. Strategies aimed at blocking vascular ETAR/ETBR and astrocyte ETBRs following spinal cord injury may reduce the resulting ischemia and astrogliosis and in doing so increase neuronal survival, regeneration, and function.

AB - The endothelins (ETs) are a family of peptides that exert their biological effects via two distinct receptors, the endothelin A receptor (ETAR) and the endothelin B receptor (ETBR). To more clearly define the potential actions of ETs following spinal cord injury, we used immunohistochemistry and confocal microscopy to examine the protein expression of ETAR and ETBR in the normal and injured rat spinal cord. In the normal spinal cord, ETAR immunoreactivity (IR) is expressed by vascular smooth muscle cells and a subpopulation of primary afferent nerve fibers. ETBR-IR is expressed primarily by radial glia, a small population of gray and white matter astrocytes, ependymal cells, vascular endothelial cells, and to a lesser extent in smooth muscle cells. Fourteen days following compression injury to the spinal cord, there was a significant upregulation in both the immunoexpression and number of astrocytes expressing the ETBR in both gray and white matter and a near disappearance of ETBR-IR in ependymal cells and ETAR-IR in primary afferent fibers. Conversely, the vascular expression of ETAR and ETBR did not appear to change. As spinal cord injury has been shown to induce an immediate increase in plasma ET levels and a sustained increase in tissue ET levels, ETs would be expected to induce an initial marked vasoconstriction via activation of vascular ETAR/ETBR and then days later a glial hypertrophy via activation of the ETBR expressed by astrocytes. Strategies aimed at blocking vascular ETAR/ETBR and astrocyte ETBRs following spinal cord injury may reduce the resulting ischemia and astrogliosis and in doing so increase neuronal survival, regeneration, and function.

KW - Astrocytes

KW - CNS injury

KW - Endothelial cells

KW - Endothelin

KW - Regeneration

KW - Secondary injury

KW - Smooth muscle cells

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=0037350084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037350084&partnerID=8YFLogxK

U2 - 10.1016/S0014-4886(02)00023-7

DO - 10.1016/S0014-4886(02)00023-7

M3 - Article

C2 - 12668144

AN - SCOPUS:0037350084

VL - 180

SP - 1

EP - 13

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -